201 related articles for article (PubMed ID: 7770611)
1. Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT1A and 5-HT1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats.
Bosker FJ; van Esseveldt KE; Klompmakers AA; Westenberg HG
Psychopharmacology (Berl); 1995 Feb; 117(3):358-63. PubMed ID: 7770611
[TBL] [Abstract][Full Text] [Related]
2. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis.
Nakai K; Fujii T; Fujimoto K; Suzuki T; Kawashima K
Neurosci Res; 1998 May; 31(1):23-9. PubMed ID: 9704975
[TBL] [Abstract][Full Text] [Related]
3. A brain microdialysis study on 5-HT release in freely moving rat lines selectively bred for differential 5-HT1A receptor function.
Gonzalez LE; Parada MA; Tucci S; Teneud L; Overstreet DH; Hernandez L
Braz J Med Biol Res; 2003 Feb; 36(2):263-7. PubMed ID: 12563529
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
Dong J; De Montigny C; Blier P
Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-induced adaptive changes in the effects of 5-HT, 5-HT1A and 5-HT4 agonists on the population spike recorded in hippocampal CA1 cells do not involve presynaptic effects on excitatory synaptic transmission.
Tokarski K; Bijak M
Pol J Pharmacol; 1996; 48(6):565-73. PubMed ID: 9112695
[TBL] [Abstract][Full Text] [Related]
6. The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice.
De Groote L; Olivier B; Westenberg HG
Eur J Pharmacol; 2002 Mar; 439(1-3):93-100. PubMed ID: 11937097
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
Tordera RM; Monge A; Del Río J; Lasheras B
Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
[TBL] [Abstract][Full Text] [Related]
8. Lack of 5-HT1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis.
Hjorth S; Auerbach SB
Neuropharmacology; 1994; 33(3-4):331-4. PubMed ID: 7984270
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
Casanovas JM; Vilaró MT; Mengod G; Artigas F
J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine.
de Jong TR; Pattij T; Veening JG; Waldinger MD; Cools AR; Olivier B
Psychopharmacology (Berl); 2005 May; 179(2):509-15. PubMed ID: 15719219
[TBL] [Abstract][Full Text] [Related]
11. Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: an in vivo microdialysis study.
Gur E; Lerer B; Newman ME
J Neural Transm (Vienna); 1997; 104(8-9):795-804. PubMed ID: 9451712
[TBL] [Abstract][Full Text] [Related]
12. Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram.
Invernizzi R; Bramante M; Samanin R
Brain Res; 1995 Oct; 696(1-2):62-6. PubMed ID: 8574685
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
[TBL] [Abstract][Full Text] [Related]
14. Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat.
Bosker FJ; Klompmakers AA; Westenberg HG
Neuropharmacology; 1995 May; 34(5):501-8. PubMed ID: 7566484
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.
Gardier AM; David DJ; Jego G; Przybylski C; Jacquot C; Durier S; Gruwez B; Douvier E; Beauverie P; Poisson N; Hen R; Bourin M
J Neurochem; 2003 Jul; 86(1):13-24. PubMed ID: 12807420
[TBL] [Abstract][Full Text] [Related]
16. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
Dekeyne A; Brocco M; Adhumeau A; Gobert A; Millan MJ
Psychopharmacology (Berl); 2000 Sep; 152(1):55-66. PubMed ID: 11041316
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of 5-HT1B and 5-HT1D receptor antagonist effects on extracellular 5-HT levels in the guinea-pig brain following concurrent 5-HT1A or 5-HT re-uptake site blockade.
Roberts C; Boyd DF; Middlemiss DN; Routledge C
Neuropharmacology; 1999 Sep; 38(9):1409-19. PubMed ID: 10471095
[TBL] [Abstract][Full Text] [Related]
18. [Effects of (+/-)-pindolol over increased extracellular 5-HT level induced by fluvoxamine: regional difference in effect among the raphe, dorsal hippocampus and prefrontal cortex as measured by in vivo microdialysis technique].
Nakada S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 May; 20(2):51-60. PubMed ID: 11062862
[TBL] [Abstract][Full Text] [Related]
19. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
Invernizzi R; Bramante M; Samanin R
Pharmacol Biochem Behav; 1996 May; 54(1):143-7. PubMed ID: 8728551
[TBL] [Abstract][Full Text] [Related]
20. Single-dose 8-OH-DPAT pretreatment does not induce tachyphylaxis to the 5-HT release-reducing effect of 5-HT1A autoreceptor agonists.
Hjorth S
Eur J Pharmacol; 1991 Jun; 199(2):237-42. PubMed ID: 1835441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]